SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-18-018708
Filing Date
2018-06-29
Accepted
2018-06-29 16:00:25
Documents
1
Period of Report
2018-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6416
  Complete submission text file 0000899243-18-018708.txt   7971
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10

Mailing Address SUITE 4 LEVEL 46 2 PARK STREET SIDNEY C3 2000
Business Address
Godshall Douglas Evan (Reporting) CIK: 0001404227 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51122 | Film No.: 18929265